We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Buying $100 In GMED: If an investor had bought $100 of GMED stock 10 years ago, it would be worth $356.36 today based on a price of $86.88 for GMED at the time of writing.

Berkshire Hathaway Inc. Cl A 1.98% $1.02T Berkshire Hathaway Inc. Cl B 1.86% $1.02T VF Corp. 5.76% $9.41B Under Armour Inc. Cl C 1.82% $2.96B Under Armour Inc. Cl A 1.96% $2.96B ...

Innovative Industrial Properties Inc. 9% Cum. Conv. Redeem. Pfd. Series A-0.15% Digital Realty Trust Inc. 5.25% Cum. Conv. Pfd. Series J 1.46% Digital Realty Trust Inc. 5.2% Cum. Redeem.

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites. A small percentage of patients taking the ...

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...